| Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete, H Tegally, JE San, ... Nature 602 (7898), 654-656, 2022 | 1127 | 2022 |
| Escape of SARS-CoV-2 501Y. V2 from neutralization by convalescent plasma S Cele, I Gazy, L Jackson, SH Hwa, H Tegally, G Lustig, J Giandhari, ... Nature 593 (7857), 142-146, 2021 | 701 | 2021 |
| T cell responses to SARS-CoV-2 spike cross-recognize Omicron R Keeton, MB Tincho, A Ngomti, R Baguma, N Benede, A Suzuki, K Khan, ... Nature 603 (7901), 488-492, 2022 | 569 | 2022 |
| SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection S Cele, L Jackson, DS Khoury, K Khan, T Moyo-Gwete, H Tegally, JE San, ... MedRxiv, 2021 | 371 | 2021 |
| SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape S Cele, F Karim, G Lustig, JE San, T Hermanus, H Tegally, J Snyman, ... Cell host & microbe 30 (2), 154-162. e5, 2022 | 208 | 2022 |
| Group 3 innate lymphoid cells mediate early protective immunity against tuberculosis A Ardain, R Domingo-Gonzalez, S Das, SW Kazer, NC Howard, A Singh, ... Nature 570 (7762), 528-532, 2019 | 199 | 2019 |
| Omicron BA. 4/BA. 5 escape neutralizing immunity elicited by BA. 1 infection K Khan, F Karim, Y Ganga, M Bernstein, Z Jule, K Reedoy, S Cele, ... Nature communications 13 (1), 4686, 2022 | 163 | 2022 |
| Escape of SARS-CoV-2 501Y S Cele, I Gazy, L Jackson, SH Hwa, H Tegally, G Lustig, J Giandhari, ... V2 variants from neutralization by convalescent plasma. medRxiv 2026 (10 …, 2021 | 127 | 2021 |
| Persistent SARS-CoV-2 infection and intra-host evolution in association with advanced HIV infection F Karim, MYS Moosa, BI Gosnell, S Cele, J Giandhari, S Pillay, H Tegally, ... MedRxiv, 2021.06. 03.21258228, 2021 | 105 | 2021 |
| Tissue-resident-like CD4+ T cells secreting IL-17 control Mycobacterium tuberculosis in the human lung P Ogongo, LB Tezera, A Ardain, S Nhamoyebonde, D Ramsuran, A Singh, ... The Journal of clinical investigation 131 (10), 2021 | 90 | 2021 |
| Omicron sub-lineages BA. 4/BA. 5 escape BA. 1 infection elicited neutralizing immunity K Khan, F Karim, Y Ganga, M Bernstein, Z Jule, K Reedoy, S Cele, ... MedRxiv, 2022.04. 29.22274477, 2022 | 82 | 2022 |
| A novel sample processing method for rapid detection of tuberculosis in the stool of pediatric patients using the Xpert MTB/RIF assay PP Banada, U Naidoo, S Deshpande, F Karim, JAL Flynn, M O’Malley, ... PloS one 11 (3), e0151980, 2016 | 81 | 2016 |
| Omicron infection enhances Delta antibody immunity in vaccinated persons K Khan, F Karim, S Cele, K Reedoy, JE San, G Lustig, H Tegally, ... Nature 607 (7918), 356-359, 2022 | 79 | 2022 |
| Subtherapeutic concentrations of first-line anti-TB drugs in South African children treated according to current guidelines: the PHATISA study H Hiruy, Z Rogers, C Mbowane, J Adamson, L Ngotho, F Karim, T Gumbo, ... Journal of Antimicrobial Chemotherapy 70 (4), 1115-1123, 2015 | 76 | 2015 |
| Evolution and neutralization escape of the SARS-CoV-2 BA. 2.86 subvariant K Khan, G Lustig, C Römer, K Reedoy, Z Jule, F Karim, Y Ganga, ... Nature communications 14 (1), 8078, 2023 | 71 | 2023 |
| A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy AJ Greaney, TN Starr, RT Eguia, AN Loes, K Khan, F Karim, S Cele, ... PLoS pathogens 18 (2), e1010248, 2022 | 62 | 2022 |
| SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron R Keeton, MB Tincho, A Ngomti, R Baguma, N Benede, A Suzuki, K Khan, ... MedRxiv, 2021.12. 26.21268380, 2021 | 61 | 2021 |
| Omicron infection of vaccinated individuals enhances neutralizing immunity against the Delta variant K Khan, F Karim, S Cele, JE San, G Lustig, H Tegally, Y Rosenberg, ... Medrxiv, 2021.12. 27.21268439, 2022 | 54 | 2022 |
| Differential skewing of donor-unrestricted and γδ T cell repertoires in tuberculosis-infected human lungs P Ogongo, AJC Steyn, F Karim, KJ Dullabh, I Awala, R Madansein, ... The Journal of clinical investigation 130 (1), 214-230, 2020 | 53 | 2020 |
| HIV status alters disease severity and immune cell responses in Beta variant SARS-CoV-2 infection wave F Karim, I Gazy, S Cele, Y Zungu, R Krause, M Bernstein, K Khan, ... Elife 10, e67397, 2021 | 50 | 2021 |
Alex SigalProfessor, Hebrew University and Africa Health Research InstituteVahvistettu sähköpostiosoite verkkotunnuksessa AHRI.org
